Anthropic has surged to a trillion-dollar valuation on secondary markets, overtaking OpenAI.

The key signal here is not just enthusiasm for one AI asset, but the emergence of a scarcity premium in private AI exposure. That tends to spill over into adjacent beneficiaries: secondary platforms, fund managers with access, and any vehicle that can warehouse or intermediate illiquid growth equity. FRGE benefits mechanically from wider bid/ask activity and more motivated price discovery, but the bigger second-order effect is that every mark-up in a marquee private name raises the perceived value of the entire late-stage AI cohort, tightening primary market terms and extending runway for top-tier sellers.

The distortion is that price discovery is being driven by access rather than fundamentals, which usually persists longer than skeptics expect but ends abruptly when supply normalizes. In the next 1-3 months, the main risk to the trade is seller exhaustion: if employees or early holders decide to lock gains, secondary supply can expand fast and compress the premium. Another reversal vector is a broad AI de-rating if hyperscaler capex commentary softens; in that case, the market would likely stop paying up for narrative leaders first, because they are priced for perfection.

For public-market positioning, the clean expression is to own the plumbing around private-market exuberance rather than the exuberance itself. FRGE can outperform if transaction volumes and headline pricing remain frothy, but it should be treated as a high-beta proxy for late-stage sentiment, not a durable compounder off this print alone. The contrarian read is that Anthropic's premium may actually be a topping signal for private AI risk appetite: when buyers start bidding above prior round marks by 2-3x in weeks, the marginal buyer is often price-insensitive and near exhaustion.